IDR Data
CMS PUF data · 2023 Q1–2025 Q4

Federal IDR outcomes: Urology in New Jersey

In 2025 Q1–Q4, the provider or facility offer prevailed in 90.2% of 786 determined Federal IDR dispute line items for urology in New Jersey. The median prevailing offer was 16.09x the QPA (25th–75th percentile 8.44x–26.19x; n = 733). The median time to a decision was 32 business days (n = 786).

Determined line items

786

2025 Q1–Q4 · 0 split decisions excluded

Provider win rate

90.2%

n = 786 · 2025 Q1–Q4

Median payment vs QPA

16.09x

middle half 8.44x–26.19x · n = 733 · 2025 Q1–Q4

Median days to decision

32

business days, from dispute initiation · n = 786 · 2025 Q1–Q4

Dollar amounts are not shown for specialty groups: the CMS QPA and Offers file, the only source of dollar figures, has no specialty field. See methodology.

By period

PeriodLine itemsWin %Median ×QPA25th–75thRatio nMedian days
2025 Q1–Q478690.2%16.09x8.44x–26.19x73332
2024 Q1–Q440692.9%15.52x8.34x–23.44x34827
2023 Q1–Q4Fewer than 30 determined line items; not shown.
2023 Q1–2025 Q41,20591.1%15.72x8.35x–25.07x1,094not pooled

Line items = determined dispute line items (n). Win rate excludes split decisions and includes default decisions. Ratio n = line items reporting a payment-to-QPA ratio. Days are business days as reported by CMS (2023–2024: from IDR entity assignment; 2025: from initiation) and are never pooled.

Most disputed CPT codes

CPT codeLine itemsWin %Median ×QPARatio nMedian days
52344 Repair of stricture of ureter using an endoscope17689.8%14.44x16032.5
52356 Crushing of stone of ureter with insertion of stent using an endoscope13592.6%21.67x †13329
52330 Manipulation of stone in ureter using an endoscope11691.4%11.87x10231.5
52352 Removal or manipulation of stone in ureter or kidney using an endoscope11488.6%29.20x †9837
50590 Shock wave crushing of kidney stones5791.2%8.84x5734
52332 Insertion of stent in ureter using an endoscope4395.3%48.68x †4235

2025 Q1–Q4 · rows with n ≥ 30 determined line items · sorted by n.

Related: all specialties in New Jersey · Urology in all states

FAQ

What is the Federal IDR provider win rate for urology in New Jersey?

In 2025 Q1–Q4, the provider or facility offer was selected in 90.2% of 786 determined dispute line items for urology in New Jersey. Split decisions are excluded from the denominator and default decisions are included. Withdrawn, settled and ineligible disputes are not in the CMS data.

How do Federal IDR payments compare with the QPA for urology in New Jersey?

In 2025 Q1–Q4, the median prevailing offer was 16.09x the qualifying payment amount (QPA), with a 25th to 75th percentile range of 8.44x to 26.19x (n = 733 line items). This uses the CMS field Prevailing Party Offer as % of QPA, where 1.00x equals the QPA.

How long do Federal IDR decisions take for urology in New Jersey?

In 2025 Q1–Q4, the median was 32 business days (n = 786 line items), using the CMS field Length of Time to Make Determination (from dispute initiation).

How to Utilize IDR